The UK Government has announced that following US President’s recent State Visit, £150 billion of inward investment from US companies has been secured in deals that will create more than 7,600 high-quality jobs in all areas of the UK, including 1,000 new jobs in Belfast and 6,000 more roles ‘from Glasgow to Warrington, the Midlands, and the North East’.
Outlined as being included in the investment are: a £100 billion investment pledge from the ‘alternative asset manager’
Blackstone over the next decade into the UK; £3.9 billion investment from the investment firm
Prologis, to strengthen its current investment at
Cambridge Biomedical Campus and upgrade Daventry’s International Rail Freight Terminal; a £1.5 billion in UK defence by the software company
Palantir, creating up to 350 new jobs; and a £150 million investment from American company Amentum — a government and commercial services contractor — creating more than 3,000 jobs and expanding its UK workforce by over 50%.
Meanwhile,
Boeing is to convert two 737 aircraft in Birmingham for the US Air Force, creating 150 high-skilled jobs, and the US Engineering firm
STAX has committed £37 million to expand its UK operations and ‘pioneer emissions-reducing technology at ports around the country’.
Jobs, growth and opportunityPrime Minister Keir Starmer said: “These investments are a testament to Britain’s economic strength and a bold signal that our country is open, ambitious, and ready to lead. Jobs, growth and opportunity is what I promised for working people, and it is exactly what this State Visit is delivering.”
Business and Trade Secretary Peter Kyle added: “These record-breaking investments will create thousands of high-quality jobs across the UK — from clean energy to advanced manufacturing. It’s a huge vote of confidence in our economy and shows that working closely with the US strengthens our global position and delivers real results for British businesses.”
Alongside the record-breaking inward investment package, UK companies are also making significant commitments to invest the US market. They include: the British pharmaceutical company
GSK investing nearly £22 billion into US R&D and manufacturing over five years;
BP investing over £3.6 billion annually in the USA for the next five years; the tech company
Sage committing £1.6 billion in operational spending in the USA over three years, reflecting strong market growth and 40% US investor ownership; and
OakNorth Bank investing over $5 billion into the US market over the next three years.